Department of Pharmacology and Biopharmaceutics, Key Laboratory of Drug Targeting and Drug Delivery Systems Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China.
J Ethnopharmacol. 2012 Jan 31;139(2):440-6. doi: 10.1016/j.jep.2011.11.030. Epub 2011 Nov 26.
Salvia miltiorrhiza has long been used in the traditional Chinese formulations for the treatment of heart ischemic diseases.
We investigated the cardioprotective effect of purified Salvia miltiorrhiza extract (SME) in an experimental model of acute myocardial infarction.
Following induction of acute myocardial infarction in rats by adminstration of isoproterenol, hemodynamic and electrocardiographic parameters were monitored and recorded continuously, cardiac enzymes and parameters of oxidative stress were measured, and histopathological examination of heart tissue was performed. Experiments were performed in rats treated with SME or vehicle, as well as in those treated with Fufang Danshen Tablet (FDT) as a positive control which has previously been shown to prevent myocardial ischemia.
Isoproterenol-treated rats showed reductions in left ventricular systolic pressure as well as in maximum and minimum rate of developed left ventricular pressure, together with an increase in left ventricular end-diastolic pressure. They also demonstrated ST-segment elevation, together with increases in serum levels of lactate dehydrogenase, glutamic oxalacetic transaminase, creatine kinase and malondialdehyde, as well as decreases in serum activities of glutathione peroxidase and superoxide dismutase. Oral administration of SME (29.76 or 59.52 mg/kg) blunted all of the hemodynamic and biochemical changes induced by isoproterenol, as did FDT (1210 mg/kg). The protective effect of SME on isoproterenol-induced myocardial damage was further confirmed by histopathological examination.
Our results suggest that SME affords protection against isoproterenol-induced myocardial infarction.
丹参已在中国传统方剂中使用多年,用于治疗缺血性心脏病。
本研究旨在研究丹参提取物(SME)对实验性急性心肌梗死的心脏保护作用。
通过异丙肾上腺素给药诱导大鼠急性心肌梗死,连续监测和记录血流动力学和心电图参数,测量心肌酶和氧化应激参数,并进行心脏组织的组织病理学检查。实验在给予 SME 或载体的大鼠以及给予已证明可预防心肌缺血的复方丹参片(FDT)的阳性对照组大鼠中进行。
异丙肾上腺素处理的大鼠左心室收缩压降低,左心室压力最大和最小发展率降低,左心室舒张末期压力升高。它们还表现出 ST 段抬高,血清乳酸脱氢酶、谷氨酸草酰乙酸转氨酶、肌酸激酶和丙二醛水平升高,血清谷胱甘肽过氧化物酶和超氧化物歧化酶活性降低。SME(29.76 或 59.52mg/kg)口服给药可减轻异丙肾上腺素引起的所有血流动力学和生化变化,FDT(1210mg/kg)也是如此。SME 对异丙肾上腺素诱导的心肌损伤的保护作用通过组织病理学检查进一步得到证实。
我们的结果表明,SME 对异丙肾上腺素诱导的心肌梗死具有保护作用。